Business Wire

GHX

Share
GHX Announces Agreement to Acquire Majority of Assets of Medical Columbus

Global Healthcare Exchange (GHX ), a leader in cloud-based healthcare supply chain management solutions, today announced that it has entered into an agreement to acquire a majority of the assets and employees of Germany-based Medical Columbus AG , a provider of healthcare procurement software for providers and suppliers across Germany, Switzerland, Austria, Luxembourg, and the Netherlands. The acquisition expands GHX’s European supply chain and procurement products portfolio to deliver even greater efficiency and value to the healthcare community. The acquisition is expected to close in about three months.

Both companies’ solutions serve providers, suppliers and group purchasing organizations (GPOs) in healthcare. The combined product offering gives GHX the ability to expand its procurement solutions offering and its trading partner network in key markets in Europe while helping to deliver operational efficiencies for both providers and suppliers in Germany, Switzerland, Austria, Luxembourg and the Netherlands. GHX has been operating in Europe since 2000.

“The solutions and employee team we are acquiring is a tremendous addition to GHX Europe,” said Bruce Johnson, CEO and president of GHX. “With this acquisition, we are enhancing our solutions portfolio and expanding our footprint in Europe. This is great for our multi-national suppliers and local European provider customers by providing them with a larger pool of potential trading partners that can fuel increased business process efficiencies.”

Added Dirk Isenberg, CEO at Medical Columbus, “We are pleased to be joining with GHX to help drive down costs in healthcare, allowing our customers access to best of breed e-catalogue and e-procurement solutions.”

With more than 4,000 hospitals and 18,000 provider facilities worldwide in the GHX community, the acquisition reinforces GHX’s commitment to remove cost from healthcare by continuing to grow a global trading partner network that benefits both provider and suppliers.

ABOUT MEDICAL COLUMBUS

Founded in 1998, Medical Columbus is one of the e-health pioneers focusing on procurement processes. The company's transaction platform synchronizes the various IT systems and catalog data from medical device, pharmaceutical industry, and hospital customers. By standardizing data and processes, mistakes are avoided, processing times are shortened, and costs for suppliers and providers are significantly reduced. Medical Columbus products are best of breed in modern healthcare supply chain solutions. For more information, visit www.medicalcolumbus.de .

ABOUT GHX EU

Global Healthcare Exchange, LLC (GHX) is a healthcare and data automation company, empowering healthcare organizations to enable better patient care and maximize savings using its world-class cloud-based supply chain technology platform, solutions, analytics and services. GHX brings together healthcare providers, manufacturers and distributors in North America, and Europe, who rely on smart, secure healthcare-focused technology and comprehensive data to automate business processes and make more informed, timely and fact-based decisions. Solutions span procurement and accounts payable automation, contract and inventory management, vendor credentialing and management, business intelligence, payment management and other supply chain-related tools and services. For more information, visit www.ghx.com/europe/en (Europe), www.ghx.com (North America), and The Healthcare Hub blog.

Contact:

GHX Europe:
4iMedia
Viktoria Skrzypek, +49 (0) 341 870 98 4-38
Viktoria.Skrzypek@4iMEDIA.com
or
GHX North America:
Tier One Partners
Kathy Wilson, 781-652-0499
kwilson@tieronepr.com
or
Medical Columbus:
Dirk Isenberg, +49 (0) 6174 9617 18
Dirk.isenberg@medicalcolumbus.de

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Ant International Announces Sustainability Framework, Serving 100 mn Merchants to Advance Inclusive Growth in Re-globalisation16.6.2025 07:00:00 CEST | Press release

- The now-independent company combines techfin and sustainability work in 6T areas: travel, trade, thrive, technology, talent and trust - Company will focus on innovation and collaboration with public & private sectors across 4 business pillars: Unified global wallet gateway, unified merchant payment service, global business account service, and embedded finance service. Ant International, a leading global digital payment, digitisation and financial technology provider, today announced its Sustainability Framework in its first independent Sustainability Report. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250615891282/en/ Ant International announces Sustainability Framework in its Inaugural Sustainability Report A New Chapter of Growth with New Mission and Vision at a Critical Moment 2024 is a transformative year for Ant International, which became independent after a reorganisation of Ant Group. With headquarters in Singa

Andersen Consulting tilføjer Sidat Hyder Morshed til platformen gennem samarbejdsaftale15.6.2025 20:08:00 CEST | Pressemeddelelse

Andersen Consulting indgår en samarbejdsaftale med Sidat Hyder Morshed Associates (Sidat Hyder), et managementkonsulent- og teknologiservicefirma, og styrker dermed sin globale kapacitet og tilstedeværelse på et voksende marked. Sidat Hyder blev stiftet i 1986 og tilbyder en lang række ydelser, herunder strategi- og ledelsesrådgivning, HR-rådgivning, rekruttering og outsourcing samt finansiel rådgivning. Firmaet servicerer en mangfoldig portefølje af kunder på tværs af sektorer som finansielle tjenester, energi, produktion, telekommunikation og den offentlige sektor. "Vi har tidligere fungeret som et repræsentativt firma for Arthur Andersen i Pakistan, og vi har en dyb forpligtelse til kvalitet, gennemsigtighed og den bedste service i klassen – værdier, som også er forankret i kulturen hos Andersen Consulting," siger Waqar Hyder, administrerende direktør for Sidat Hyder. "Som samarbejdsfirma er vi nu en del af en platform i verdensklasse, som styrker vores kapacitet, når det kommer til

Cosmetics Industry Icon Leonard A. Lauder, Chairman Emeritus, The Estée Lauder Companies, Passes Away15.6.2025 18:54:00 CEST | Press release

It is with deep sadness that The Estée Lauder Companies Inc. (NYSE: EL) announces that Chairman Emeritus Leonard A. Lauder passed away on June 14, at the age of 92, surrounded by family. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250615313230/en/ Leonard A. Lauder Mr. Lauder was born in 1933 in New York City, the oldest son of Estée and Joseph H. Lauder, the founders of The Estée Lauder Companies. He was a graduate of the Bronx High School of Science, the University of Pennsylvania’s Wharton School, and the Officer Candidate School of the United States Navy. Mr. Lauder studied at Columbia University’s Graduate School of Business. He served as a lieutenant in the U.S. Navy and as a Navy reservist, for which the U.S. Navy Supply Corps Foundation later recognized him with its Distinguished Alumni Award. He formally joined Estée Lauder in 1958, and for more than six decades, Mr. Lauder was a visionary and an innovator, helpi

Positive Late-Breaking Data for Incyte’s First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA202515.6.2025 09:15:00 CEST | Press release

Data demonstrates the potential for INCA033989 to modify disease by directly inhibiting and eliminating oncogenic mutCALR cells, while sparing healthy cells and restoring normal blood cell productionIn high-risk patients with essential thrombocythemia (ET) with a CALR mutation (mutCALR), 86% of INCA033989-treated patients at doses 400 mg and above achieved a complete or partial hematologic responsewith the majority (82%) realizing a complete responseA reduction in peripheral blood mutCALR variant allele frequency (VAF) was observed in 89% of evaluable patients correlating with hematologic responseInitial results demonstrate a favorable safety profile – no dose limiting toxicities were reported, a maximum tolerated dose was not reached and 98% of patients remained on treatmentIncyte will host an in-person analyst and investor event highlighting this data at EHA today, Sunday, June 15, 2025, from 6:00 - 7:30 a.m. EDT (12:00 -1:30 p.m. CEST) Incyte (Nasdaq:INCY) today announced the first

Perma-Pipe International Holdings, Inc. Announces First Quarter Fiscal 2025 Financial Results13.6.2025 15:14:00 CEST | Press release

The Company generated net sales of $46.7 million compared to $34.3 million in the first quarter of 2024Income before income taxes of $7.4 million versus $2.6 million in the first quarter of 2024Backlog of $131.1 million at April 30, 2025, compared to $63.1 million at April 30, 2024 Perma-Pipe International Holdings, Inc. (NASDAQ: PPIH) announced today financial results for the first quarter ended April 30, 2025. “Sales for the first quarter were $46.7 million, resulting in an increase of $12.4 million, or 36.2%, compared to $34.3 million in the same quarter last year. Net income attributable to common stock of $5.0 million was an increase of $3.6 million, or 243%, compared to $1.4 million in the first quarter of the prior year,” noted President and CEO Saleh Sagr. Backlog currently stands at $131.1 million, a decrease of $7.0 million, compared to $138.1 million at January 31, 2025. However, the Company has experienced a significant increase in backlog of $68.0 million, or 108%, compare

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye